Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Regulatory News

Date Source Headline
25th Apr 2019 7:00 am RNS Gelesis Gets $10.6M Grant to Support Manufacturing
24th Apr 2019 7:00 am RNS Final Results
17th Apr 2019 7:00 am RNS Boehringer Ingelheim & PRTC Immuno-oncology Collab
15th Apr 2019 7:00 am RNS Gelesis Receives FDA Clearance for First Product
11th Apr 2019 1:00 pm RNS Akili Makes CFO & General Counsel Appointments
11th Apr 2019 7:05 am RNS Gelesis Presents Data on Effects of High-Fat Diet
11th Apr 2019 7:00 am RNS Sonde Completes $16M Series A Financing Round
2nd Apr 2019 7:00 am RNS PRTC Presents Immuno-Oncology Programmes at AACR
1st Apr 2019 12:05 pm RNS Karuna expands Series B financing to $80 million
25th Mar 2019 6:00 pm RNS Gelesis New Clinical Data on Impact of Gelesis100
25th Mar 2019 6:00 pm RNS Gelesis Preclinical Data on Restoring Gut Barrier
21st Mar 2019 7:00 am RNS Gelesis to Present at Endocrine Society Annual Mtg
18th Mar 2019 7:00 am RNS Karuna Announces $68 Million Series B Financing
15th Mar 2019 7:00 am RNS Notice of Results
7th Mar 2019 7:00 am RNS Akili & Shionogi Deal in Taiwan/Japan $20M upfront
5th Mar 2019 7:00 am RNS Karuna Appoints Chief Financial Officer
22nd Feb 2019 4:41 pm RNS Second Price Monitoring Extn
22nd Feb 2019 4:36 pm RNS Price Monitoring Extension
21st Feb 2019 7:00 am RNS PRTC to Present at Two US Investor Conferences
15th Feb 2019 4:41 pm RNS Second Price Monitoring Extn
15th Feb 2019 4:35 pm RNS Price Monitoring Extension
14th Feb 2019 7:00 am RNS Vor Raises $42M to Advance Leukaemia Treatment
28th Jan 2019 7:00 am RNS Alivio Partners to Advance Non-opioid Pain Therapy
23rd Jan 2019 6:08 pm RNS Vedanta Immuno-oncology Candidate Published
2nd Jan 2019 7:00 am RNS Total Voting Rights
28th Dec 2018 12:07 pm RNS Second Price Monitoring Extn
28th Dec 2018 12:02 pm RNS Price Monitoring Extension
24th Dec 2018 7:00 am RNS Vedanta Biosciences Raise $27M Series C Financing
17th Dec 2018 7:00 am RNS Vedanta Initiates Phase 2 Study for Lead Candidate
10th Dec 2018 7:00 am RNS Vedanta & BMS Immuno-Oncology Collaboration
28th Nov 2018 7:00 am RNS Vor Granted First-in-class Immuno-oncology Patent
27th Nov 2018 7:00 am RNS Janssen/Vedanta Phase 1 in IBD & $12M Milestone
26th Nov 2018 4:40 pm RNS Second Price Monitoring Extn
26th Nov 2018 4:35 pm RNS Price Monitoring Extension
22nd Nov 2018 12:07 pm RNS Second Price Monitoring Extn
22nd Nov 2018 12:02 pm RNS Price Monitoring Extension
16th Nov 2018 12:07 pm RNS Second Price Monitoring Extn
16th Nov 2018 12:02 pm RNS Price Monitoring Extension
14th Nov 2018 12:07 pm RNS Second Price Monitoring Extn
14th Nov 2018 12:02 pm RNS Price Monitoring Extension
FTSE 100 Latest
Value8,328.60
Change52.94